Therapy for Children With Advanced Stage Neuroblastoma
Phase 2 Completed
153 enrolled 12 charts
Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer
Phase 1 Completed
10 enrolled
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Phase 2 Completed
40 enrolled 15 charts
HESTIA
Phase 1 Completed
32 enrolled
FORTE
Phase 2 Completed
477 enrolled
INCA
Phase 2 Completed
129 enrolled 7 charts
FCR
Phase 2 Completed
21 enrolled 9 charts
Auto-LLC 2001
Phase 3 Completed
241 enrolled
NeoSACT
Phase 2 Completed
29 enrolled
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
Phase 1 Completed
17 enrolled
Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies
Phase 1 Completed
52 enrolled 15 charts
Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
Phase 1/2 Completed
51 enrolled 16 charts
Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery
Phase 2 Completed
20 enrolled 12 charts
PAL-ANGI
Phase 2 Completed
88 enrolled
PAL-ANGI2
Phase 1 Completed
28 enrolled
PALANGI3
Phase 1 Completed
26 enrolled
Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer
Phase 2 Completed
58 enrolled 9 charts
Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
Phase 1/2 Completed
55 enrolled 17 charts
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
Phase 2 Completed
15 enrolled 13 charts
Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma
Phase 2 Completed
40 enrolled 21 charts
Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer
Phase 2 Completed
41 enrolled 9 charts
Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma
Phase 2 Completed
17 enrolled 11 charts
Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma
Phase 1 Completed
9 enrolled 10 charts
Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies
Phase 1/2 Completed
87 enrolled 24 charts
05-001: Treatment of Acute Lymphoblastic Leukemia in Children
Phase 3 Completed
800 enrolled 22 charts
Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
Phase 2 Completed
29 enrolled 15 charts
Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
Phase 2 Completed
30 enrolled
BDH-MCL01
Phase 4 Completed
55 enrolled
Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia
Phase 1 Completed
2 enrolled
Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients
Phase 3 Completed
482 enrolled 2 FDA
Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies
Phase 1 Completed
3 enrolled
Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa
Phase 2 Completed
23 enrolled 10 charts
A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity
Phase 2 Completed
51 enrolled
A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD)
Phase 1 Completed
15 enrolled
ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors
Phase 1/2 Completed
5 enrolled
CD30 CAR for CD30+ NSGCT
Phase 2 Completed
2 enrolled
......SMARTEST Trial......
Phase 2 Completed
30 enrolled
Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma
Phase NA Completed
19 enrolled 7 charts
Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts
Phase NA Completed
13 enrolled 10 charts
Off-the-shelf NK Cells + SCT for Myeloid Malignancies
Phase 2 Completed
24 enrolled 9 charts
MUKEight
Phase 2 Completed
112 enrolled
Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer
Phase 3 Completed
559 enrolled
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment
Phase 3 Completed
1,023 enrolled
A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors
Phase 2 Completed
78 enrolled 13 charts
PEMBROSARC
Phase 2 Completed
129 enrolled 17 charts
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
Phase 1 Completed
16 enrolled 10 charts
ICLL07GAI
Phase 2 Completed
135 enrolled
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
Phase 1 Completed
50 enrolled
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
Phase 2 Completed
62 enrolled 15 charts
Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma
Phase 2 Completed
12 enrolled 8 charts